Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “β -Thalassemia”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05356195
What this trial is testing

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

Who this might be right for
Beta-ThalassemiaThalassemiaGenetic Diseases, Inborn+2 more
Vertex Pharmaceuticals Incorporated 16
Testing effectiveness (Phase 2)Ended earlyNCT01571635
What this trial is testing

Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

Who this might be right for
Beta Thalassemia MajorBeta Thalassemia Intermedia
Celgene 46
Large-scale testing (Phase 3)UnknownNCT02604368
What this trial is testing

A Sickle CEll Disease ComplicatioN Trial

Who this might be right for
Sickle Cell Disease
Micelle BioPharma Inc 210
Very early researchNot Yet RecruitingNCT07190001
What this trial is testing

YOLT-204 in Patients With Hemoglobinopathies

Who this might be right for
Hemoglobinopathies (Transfusion-dependent β-thalassemia and Sickle Cell Disease)
Guangzhou Women and Children's Medical Center 18
Not applicableLooking for participantsNCT06219239
What this trial is testing

Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China 3
Very early researchLooking for participantsNCT05762510
What this trial is testing

A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]

Who this might be right for
Transfusion Dependent Beta-Thalassemia
First Affiliated Hospital of Guangxi Medical University 5
Not applicableUnknownNCT03822585
What this trial is testing

Detection Of β-thalassemia Carriers In Assiut

Who this might be right for
Beta-Thalassemia
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00171210
What this trial is testing

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Who this might be right for
Transfusional Iron Overload in β-thalassemia
Novartis Pharmaceuticals 506
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07721480
What this trial is testing

Gene Therapy for Patients With Transfusion-Dependent β-Thalassemia

Who this might be right for
Beta Thalassemia Transfusion Dependent
Prince of Wales Hospital, Shatin, Hong Kong 6
Not applicableStudy completedNCT01319552
What this trial is testing

Fresh Versus Old Red Blood Cells for Transfusion

Who this might be right for
Iron, Abnormal Blood LevelOther Abnormal Blood Chemistry
Columbia University 14
Not applicableStudy completedNCT02626689
What this trial is testing

To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care

Who this might be right for
Beta-Thalassemia
Celgene 100
Not applicableNot Yet RecruitingNCT07614217
What this trial is testing

Oral Health Status in Children With β-Thalassemia Major

Who this might be right for
B Thalassemia Major
Cairo University 45
Not applicableStudy completedNCT04390971
What this trial is testing

Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
Institute of Hematology & Blood Diseases Hospital, China 3
Testing effectiveness (Phase 2)Ended earlyNCT04059406
What this trial is testing

Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)

Who this might be right for
Beta Thalassemia Intermedia
Ionis Pharmaceuticals, Inc. 29
Not applicableLooking for participantsNCT07207577
What this trial is testing

Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD

Who this might be right for
Beta Thalassemia Transfusion Dependent
Centre Hospitalier Metropole Savoie 36
Testing effectiveness (Phase 2)Looking for participantsNCT06280378
What this trial is testing

Β-Thalassemia Treatment with KL003 Cell Injection

Who this might be right for
Transfusion-dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd. 41
Early research (Phase 1)Ended earlyNCT04925206
What this trial is testing

A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
EdiGene (GuangZhou) Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT00586209
What this trial is testing

L-Glutamine Therapy for Sickle Cell Anemia

Who this might be right for
Sickle Cell AnemiaThalassemia
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 15
Early research (Phase 1)UnknownNCT05777733
What this trial is testing

NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major

Who this might be right for
Thalassemia Major
Assiut University 100
Not applicableUnknownNCT03358498
What this trial is testing

Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox

Who this might be right for
β-thalassemia
Assiut University 75
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation